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preterm stop of the therapy thus jeopardizing the intended 
treatment outcome. Despite numerous research attempts 
there is still no robust feature established in clinical routine 
to predict radiotherapy-induced toxicity prior to therapy 
start. 
 
Material and Methods: The study cohort comprised 40 
patients who underwent neoadjuvant radiochemotherapy (N-
RCT) for rectal cancer (28x1.8 Gy, 5 times weekly, 
concomitant with two cycles 5-FU-based chemotherapy). 
From each of those patients dermal fibroblasts were cultured 
from skin specimen gained outside of the radiotherapy 
planning target volume at occasion of surgery conducted 
about six weeks upon N-RCT completion. Acute radiotoxicity 
was thoroughly monitored throughout the N-RCT series and 
documented according to CTC classification. Maximal acute 
toxicity (MAT) was defined by the highest CTC grade of the 
four items “cystitis”, “proctitis”, “enteritis”, and 
“dermatitis”. MAT was grouped into grades 0/1 (n=16), 2 
(n=16), and 3/4 (n=8). N-RCT was simulated in the cultured 
fibroblasts for five consecutive days (1.8 Gy each at d1-d5 
with addiation of 5-FU at a concentration reflecting clinical 
steady-state levels) followed by a 7-day wash-out period. 
Gene expression of nine candidate genes (CAT, CDKN1A, 
CTGF, SMAD2/3/4/7, TGFB1, TGFBR1) supposed to mediate 
early radiation-induced toxicity was ascertained by 
quantitative real time PCR. Samples for these RNA analyses 
were harvested at d2 and d5 (each 4 hours upon application 
of the radiation fraction) as well as at day 12 upon the wash-
out period. GAPDH and HPRT1 transcript levels served as 
reference. 
 
Results: MAT was related to radiation-induced expression 
changes of four of the considered genes in fibroblasts. The 
strongest impact was obtained for SMAD7 and CAT at d5. The 
higher the MAT score, the lower the induction of SMAD7 and 
CAT by radiation was (p=0.001 and 0.003). However, upon 
the wash-out period at d12 no statistical differences in 
dependence on the MAT score were seen anymore for these 
two genes. In contrast, a high MAT score was linked to low 
radiation-induced induction of CTGF (p=0.005) and to a faster 
decrease of the massively induced CDKN1A (p=0.03) at d12. 
At d2, a trend (p=0.06) for CAT in relation to MAT in the 
same direction as at d5 was noticed with no correlation of 
any of the other genes at this early time point. 
 
Conclusion: Radiation-induced expression changes in patient-
matched fibroblasts may serve as biomarkers to predict 
clinical radiotoxicity. Induction of SMAD7 and CAT may 
mitigate TGFbeta signalling and reactive oxygen species load 
thus saving normal tissue during radiotherapy. A protective 
role might also be attributed to sustained elevation of 
CDKN1A. The link between post-radiation induction of CTGF 
in fibroblasts and low MAT remains to be clarified. 
Understanding the mechanistic basis of these findings might 
pave the way for better protection of irradiated normal 
tissue. 
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Purpose or Objective: Erectile dysfunction (ED) is one of the 
most common complications encountered after radiotherapy 
in prostate cancer patients. The goal of this study was to 
investigate whether single nucleotide polymorphisms (SNPs) 
are associated with late ED in men treated with radiotherapy 
for prostate cancer. To this end, we designed a novel 
machine learning-based multi-SNP model using a genome-
wide association study (GWAS) dataset. 
 
Material and Methods: We analyzed 236 evaluable patients 
with at least one year of follow-up for the development of 
ED. The severity of ED was assessed using either the patient-
administered Sexual Health Inventory for Men (SHIM) or the 
clinician-assigned Mount Sinai Erectile Function (MSEF) 
scoring schema. There were 133 patients with Grade 2 or 
more ED. For our analysis, the cohort was split into two 
groups (cases/controls: MSEF 0,1 / 2,3; cases/controls: SHIM 
≤7 / ≥16). Genome-wide SNP data were available from 
Affymetrix Genome-Wide Human SNP Array 6.0. After a 
quality test including SNP missing rate>5%, minor allele 
frequency (MAF)<5%, and Hardy-Weinberg equilibrium 
(p<10E-5), 613,496 SNPs remained. 
For the validation purpose of our proposed model, the 
dataset was split into a training dataset (2/3 of samples) and 
a validation dataset (1/3 of samples). Our model building 
process was performed using the bootstrapped data from the 
training dataset. Our idea is to convert the binary outcomes 
into preconditioned continuous outcomes based on normal 
tissue complication probability (NTCP) using principal 
component analysis (PCA) and logistic regression. The 
preconditioned outcomes were used in the model building 
process using random forest regression. Then, the model was 
tested using the validation dataset. The final predicted 
outcomes were compared with the original binary outcomes 
to estimate the predictive performance. We iterated this 
process 100 times and the performance was averaged. We 
compared the performance of our proposed method 
(preconditioning random forest regression: PRFR) with other 
methods including preconditioning lasso (PL), lasso logistic 
regression (LLR), and random forest classification (RFC). 
 
Results: Univariate analysis was performed using the training 
dataset. With a threshold of p=0.001, 367 SNPs remained. 
These SNPs were fed into our model. As shown in Figure (A), 
the averaged performance with the validation dataset was 
AUC=0.62, which is better than other methods: RFC (0.57), 
PL (0.58), and LLR (0.57). The 79 patients in the validation 
dataset were binned into 6 groups according to the predicted 
risk of ED. Figure (B) shows the comparison of the model-
predicted incidence of ED with observed incidence.  
 
Conclusion: Our machine learning-based multi-SNP model 
showed the potential to better predict the radiation-induced 
late ED. However, we need to validate our model using other 
datasets. 
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Purpose or Objective: Tumor hypoxia, a common feature of 
locally advanced head and neck cancer (HNSCC), is 
associated with higher malignancy and increased 
radioresistance. The decrease of tumor hypoxia during 
